A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before

NCT04460885 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

984

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin icodec
DRUG: Insulin glargine

Sponsor

Novo Nordisk A/S